Abstract

Three field trials were conducted to evaluate the efficacy of emamectin benzoate as a treatment for sea lice, Lepeophtheirus salmonis (Krøyer) and Caligus elongatus (Nordmann), infestations on Atlantic salmon Salmo salar (L.). Trials were carried out at sea temperatures of 13.0–15.5°C and 7.2–8.5°C. Salmon naturally infested with sea lice, with mean weights of 438, 513 and 2662 g, respectively, were held in experimental pens on commercial sites. At day −1 or −2, 20 or 30 fish were sampled from each pen to determine pre-treatment numbers of lice. Emamectin benzoate was administered in-feed at a dose of 50 μg kg −1 biomass day −1 for 7 consecutive days. Sea lice were counted again on days 7, 14 and 21, and comparisons made with untreated control fish. Treatment with emamectin benzoate was effective against chalimus and motile stages of sea lice. In all three trials, treated groups were surrounded by pens of heavily infested fish and L. salmonis numbers increased over time on control fish by 87–284%, whereas over the same period, L. salmonis were reduced on treated fish by 68–98%. In the low temperature trial, reductions were slower but numbers were still 90% lower than on control fish at day 21. At the end of the third trial, both control pens were treated with hydrogen peroxide owing to heavy lice burdens. However, L. salmonis numbers rapidly increased again and at day 55, fish treated only with emamectin benzoate still had 80% fewer lice than control fish. In the two summer trials, large numbers of C. elongatus were rapidly reduced by treatment with 82–84% efficacy by day 21. Despite the potential for continuous re-infestation, oral treatment with emamectin benzoate presented an effective means of controlling all parasitic stages of L. salmonis and C. elongatus on farmed salmon, and in one trial, numbers remained lower on treated fish for at least 55 days.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.